Clinical Trial

Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma

Name: Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma — clinical trial record (NCT06826118)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A prospective collection of data on the treatment of Chinese patients with relapsed/refractory follicular lymphoma (FL) using Axicabtagene Ciloleucel Injection, and evaluation of the efficacy and safety of Axicabtagene Ciloleucel Injection in this treatment.

Trial Details

NCT Number	NCT06826118
Lead Sponsor	The First Affiliated Hospital of Xiamen University
Conditions	Lymphoma, Follicular Lymphoma, Refractory Lymphoma
Enrollment	30 participants
Start Date	2025-02-08
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-02-13